NIH Grants Policy Update Prohibits DEI Programs, Boycott of Israeli Companies
The policy change, under the "Civil Rights Protections" section of the terms and conditions for NIH awards, was posted on the NIH's website on Monday.
The Sunshine Genetics Act would establish a consortium that plans to sequence 10,000 newborns for up to 600 rare conditions.
This small branch played a big role in advancing evidence-based genetic testing, and its loss diminishes US leadership in public health, say supporters.
Danaher to Deploy Multiple 'Levers' to Cushion Impact of Tariffs, While China Remains Headwind
Premium
The firm also reported its Life Sciences segment revenues fell 4 percent in the quarter, while Diagnostics revenues decreased 3 percent.
The company raised $30 million in Series D funding earlier this year to accelerate development of its automated microbial sequencing workflow.
Autism Study Finds Prognostic Value in Combining Genetic, Early Milestone Data
Researchers found that genetic variants alone could not predict intellectual ability in most cases but were predictive in combination with clinical data.
Invivoscribe's LabPMM Nabs NY State Approval for MRD Assay
The company can now offer the FLT3 ITD MRD Assay in New York state to assess measurable residual disease to guide treatment for acute myeloid leukemia patients.
Investment Banks Initiate Coverage of Tempus, Grail
Analysts from BTIG highlighted Tempus' artificial intelligence-based genomics, while Canaccord Genuity underscored Grail's strength in pan-cancer screening.